CNO Financial Lifts Full-Year Operating EPS View by 8% After a 45% Q2 Surge
CNO sits 59% above its 52-week low of $35.24.
Summary
CNO Financial reported Q2 operating EPS of $1.26, up 45% YoY, and raised full-year 2026 operating EPS guidance by 8% to $4.60–$4.80. The quarter marked the 16th consecutive period of insurance sales growth, with records in Worksite NAP, annuity collected premiums, and client assets.
Key Events · Earnings and Guidance · CNO
-
Q2 Operating EPS Up 45%
Driven by higher insurance product margins and net investment income, operating EPS reached $1.26, compared with $0.87 in Q2 2025.
-
Full-Year Guidance Raised 8%
Reflecting strong first-half execution and sustained sales momentum, 2026 operating EPS guidance was increased to $4.60–$4.80 from the prior midpoint.
-
16th Consecutive Quarter of Sales Growth
Total new annualized premiums (NAP) rose 7% to $127.7M, with records in Worksite Division NAP, annuity collected premiums, and client assets in brokerage and advisory.
-
Capital Return Continues
The company repurchased $60M of common stock (1.3M shares at $46.57 avg) and paid $16.8M in dividends; $300.4M remains under repurchase authorization.
Analysis · CNO · Finance
A standout quarter saw operating EPS jump 45% year-over-year, fueled by broad-based insurance sales growth and solid underwriting. Management raised the full-year operating EPS guide by 8% at the midpoint, signaling confidence in sustained momentum. The 16th consecutive quarter of sales growth and record production metrics underscore the durability of the middle-market franchise. With shares trading near a 52-week high, the raised guidance and robust capital return—$60M in buybacks—reinforce the positive thesis, though the stock already reflects much of the optimism.
How filings like this one have moved
In the 30 days to Sep 23, 2026, 35.1% of the 1081 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.41%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CNO was trading at $56.00 on NYSE in the Finance sector, with a market capitalization of approximately $5B. The 52-week trading range was $35.24 to $54.09. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.